Saus: ".... in the history of a small NZ/Aus pharma hitting the world stage."
Saus/others: I do NOT think that at a market cap of more than A$ 967 mio., NEU.AX can be considered as being "a SMALL" pharma these days??
There are many, many SMALL biotech/pharma companies listed on the ASX - all trading between about A$ 10 mio. to A$ 300 mio.
wasa
- Forums
- ASX - By Stock
- NEU
- Ann: Rett Syndrome NDA accepted for Priority Review by FDA
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.87%
!
$13.09

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-158
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.09 |
Change
0.240(1.87%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.015M | 382.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 286 | $13.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.10 | 400 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 209 | 13.080 |
5 | 371 | 13.070 |
10 | 815 | 13.060 |
9 | 1728 | 13.050 |
7 | 1386 | 13.040 |
Price($) | Vol. | No. |
---|---|---|
13.090 | 1596 | 10 |
13.100 | 1133 | 13 |
13.110 | 2002 | 12 |
13.120 | 1649 | 11 |
13.130 | 1650 | 7 |
Last trade - 13.36pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online